Tilavonemab
Bepranemab
Semorinemab
Gosuranemab
Posdinemab
Tau Peptide (1-16) (human)
MK-6240
IONIS-MAPTRx
TTBK1-IN-1
Simufilam dihydrochloride
Tau Peptide (275-305) (Repeat 2 domain)
Ac-Val-Gln-aIle-Val-aTyr-Lys-NH2
(-)Clausenamide
BuChE-IN-5
3'-DMTr-dG(iBu)
T808
tau/Aβ40 aggregation-IN-1
Acetyl-PHF5 amide
Tau Peptide (255-314) (Repeat 2 Domain) (human)
hAChE-IN-1